Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study

BackgroundBrain magnetic resonance imaging (MRI) and cognitive tests can identify heritable endophenotypes associated with an increased risk of developing stroke, dementia and Alzheimer's disease (AD). We conducted a genome-wide association (GWA) and linkage analysis exploring the genetic basis of these endophenotypes in a community-based sample.MethodsA total of 705 stroke- and dementia-free Framingham participants (age 62 +9 yrs, 50% male) who underwent volumetric brain MRI and cognitive testing (1999–2002) were genotyped. We used linear models adjusting for first degree relationships via generalized estimating equations (GEE) and family based association tests (FBAT) in additive models to relate qualifying single nucleotide polymorphisms (SNPs, 70,987 autosomal on Affymetrix 100K Human Gene Chip with minor allele frequency ≥ 0.10, genotypic call rate ≥ 0.80, and Hardy-Weinberg equilibrium p-value ≥ 0.001) to multivariable-adjusted residuals of 9 MRI measures including total cerebral brain (TCBV), lobar, ventricular and white matter hyperintensity (WMH) volumes, and 6 cognitive factors/tests assessing verbal and visuospatial memory, visual scanning and motor speed, reading, abstract reasoning and naming. We determined multipoint identity-by-descent utilizing 10,592 informative SNPs and 613 short tandem repeats and used variance component analyses to compute LOD scores.ResultsThe strongest gene-phenotype association in FBAT analyses was between SORL1 (rs1131497; p = 3.2 × 10-6) and abstract reasoning, and in GEE analyses between CDH4 (rs1970546; p = 3.7 × 10-8) and TCBV. SORL1 plays a role in amyloid precursor protein processing and has been associated with the risk of AD. Among the 50 strongest associations (25 each by GEE and FBAT) were other biologically interesting genes. Polymorphisms within 28 of 163 candidate genes for stroke, AD and memory impairment were associated with the endophenotypes studied at p < 0.001. We confirmed our previously reported linkage of WMH on chromosome 4 and describe linkage of reading performance to a marker on chromosome 18 (GATA11A06), previously linked to dyslexia (LOD scores = 2.2 and 5.1).ConclusionOur results suggest that genes associated with clinical neurological disease also have detectable effects on subclinical phenotypes. These hypothesis generating data illustrate the use of an unbiased approach to discover novel pathways that may be involved in brain aging, and could be used to replicate observations made in other studies.

[1]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[2]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[3]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[4]  E. Kaplan,et al.  Neuropsychological test performance in Framingham: a descriptive study. , 1987, Psychological reports.

[5]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[6]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[7]  P. Wolf,et al.  Familial Aggregation of Stroke: The Framingham Study , 1993, Stroke.

[8]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[9]  Barry Horwitz,et al.  Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.

[10]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[11]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.

[12]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[13]  J. Meyer,et al.  Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. , 1998, American journal of medical genetics.

[14]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[15]  C. Redies,et al.  Cadherins and synaptic specificity , 1999, Journal of neuroscience research.

[16]  Kári Stefánsson,et al.  Inheritance of human longevity in Iceland , 2000, European Journal of Human Genetics.

[17]  N. Berardi,et al.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .

[18]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[19]  N. Pedersen,et al.  Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. , 2001, American journal of medical genetics.

[20]  C. Di Menza,et al.  VLDL receptor polymorphism, cognitive impairment, and dementia , 2001, Neurology.

[21]  C. Redies,et al.  Expression of R-cadherin and N-cadherin by cell groups and fiber tracts in the developing mouse forebrain: relation to the formation of functional circuits , 2001, Neuroscience.

[22]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[23]  K. Christensen,et al.  Genetic Liability in Stroke: A Long-Term Follow-Up Study of Danish Twins , 2002, Stroke.

[24]  Charles DeCarli,et al.  Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins , 2002, Biological Psychology.

[25]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[26]  Martin N. Rossor,et al.  Advanced online publication. , 2005, Nature structural biology.

[27]  Lon R. Cardon,et al.  Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia , 2002, Nature Genetics.

[28]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[29]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[30]  Mark Gurney,et al.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke , 2003, Nature Genetics.

[31]  W. Maier,et al.  Polymorphism in the BACE gene influences the risk for Alzheimer's disease , 2003, Neuroreport.

[32]  M. Daly,et al.  Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. , 2003, Human molecular genetics.

[33]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[34]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[35]  P. Rothwell,et al.  Systematic Review of Methods and Results of Studies of the Genetic Epidemiology of Ischemic Stroke , 2003, Stroke.

[36]  J. Heemskerk,et al.  Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. , 2004, Biochemical pharmacology.

[37]  R. D'Agostino,et al.  New Norms for a New Generation: Cognitive Performance in the Framingham Offspring Cohort , 2004, Experimental aging research.

[38]  M. Leboyer,et al.  Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia , 2004, Psychiatry Research.

[39]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[40]  G. Corfas,et al.  Neuregulin1 downregulates postsynaptic GABAa receptors at the hippocampal inhibitory synapse , 2004, Hippocampus.

[41]  C. Ji,et al.  Cloning and Identification of a Novel Human Gene PDLIM5, a Homolog of AD-associated Neuronal Thread Protein (AD7c-NTP) , 2004, DNA sequence : the journal of DNA sequencing and mapping.

[42]  R B D'Agostino,et al.  Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.

[43]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[44]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[45]  Frank Dudbridge,et al.  Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. , 2004, American journal of human genetics.

[46]  B. Stegmayr,et al.  Linkage of Ischemic Stroke to the PDE4D Region on 5q in a Swedish Population , 2005, Stroke.

[47]  Y. Benjamini,et al.  Quantitative Trait Loci Analysis Using the False Discovery Rate , 2005, Genetics.

[48]  G. Kirov,et al.  Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. , 2005, Archives of general psychiatry.

[49]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[50]  Jennifer E. Chubb,et al.  DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling , 2005, Science.

[51]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[52]  M. Meisler,et al.  Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation , 2005, Journal of Medical Genetics.

[53]  L. Maffei,et al.  Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Kirov,et al.  Identification of a potential Bipolar risk haplotype in the gene encoding the winged-helix transcription factor RFX4 , 2005, Molecular Psychiatry.

[55]  Stephen W. Wilson,et al.  Early Stages of Zebrafish Eye Formation Require the Coordinated Activity of Wnt11, Fz5, and the Wnt/β-Catenin Pathway , 2005, Neuron.

[56]  M. Nöthen,et al.  Linkage analyses of chromosomal region 18p11-q12 in dyslexia , 2006, Journal of Neural Transmission.

[57]  S. Nanko,et al.  Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia , 2005, Molecular Psychiatry.

[58]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[59]  J. Qin,et al.  VEGF-integrin interplay controls tumor growth and vascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Honig,et al.  Model‐guided microarray implicates the retromer complex in Alzheimer's disease , 2005, Annals of neurology.

[61]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[62]  Suzanne Cheng,et al.  Association of Phosphodiesterase 4D Polymorphisms With Ischemic Stroke in a US Population Stratified by Hypertension Status , 2006, Stroke.

[63]  M. Itokawa,et al.  A Polymorphism in the PDLIM5 Gene Associated with Gene Expression and Schizophrenia , 2006, Biological Psychiatry.

[64]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[65]  M. Farrer,et al.  Parkinsonism, Lrrk2 G2019S, and tau neuropathology , 2006, Neurology.

[66]  Xiaoquan Wen,et al.  Coverage and Characteristics of the Affymetrix GeneChip Human Mapping 100K SNP Set , 2006, PLoS genetics.

[67]  G. Kirov,et al.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[68]  G. Silberberg,et al.  The involvement of ErbB4 with schizophrenia: Association and expression studies , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[69]  D. Stuss,et al.  Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges , 2006, Stroke.

[70]  Karin E. Borgmann-Winter,et al.  Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.

[71]  Scott M. Williams,et al.  Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. , 2006, Clinical chemistry.

[72]  S. Small,et al.  Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.

[73]  D. Gu,et al.  Association Study of G Protein‐Coupled Receptor Kinase 4 Gene Variants with Essential Hypertension in Northern Han Chinese , 2006, Annals of human genetics.

[74]  Charles DeCarli,et al.  Genome-Wide Scan for White Matter Hyperintensity: The Framingham Heart Study , 2006, Stroke.

[75]  Jason J. Corneveaux,et al.  Common Kibra Alleles Are Associated with Human Memory Performance , 2006, Science.

[76]  Yaakov Stern,et al.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. , 2007, Archives of neurology.

[77]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[78]  P Shaw,et al.  Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories , 2007, Molecular Psychiatry.

[79]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[80]  Sudha Seshadri,et al.  The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports , 2007, BMC Medical Genetics.